glp-1 blindness Lipsitz, Ponterio & Comerford Blindness and GLP-1 Drugs: An
Description
A., Torre J

Wegovy: In trials of the 25 mg pill, participants lost an average of 13.6% of body weight over 71 weeks, compared to just over 2% in the placebo group
If you have severe nausea, vomiting, dehydration, intense abdominal pain, low blood sugar symptoms, or anything that feels unusual, contact your healthcare provider

(2011) 301:H218190
doi: 10.1016/j.mce.2021.111529 [DOI] [PubMed] [Google Scholar] 149